Dr. Marcus Reid

Dr. Marcus Reid holds an MSc in Health Sciences and has spent 12 years writing about evidence-based medicine, clinical pharmacology, and mental health treatment. His work focuses on translating complex medical research into practical guidance for patients and caregivers. He has covered GLP-1 receptor agonists, metabolic medications, and weight management interventions since the first FDA approvals of semaglutide-class drugs in 2017. All YMYL content on DL Method is reviewed against current clinical guidelines before publication.

Samsung One UI 6.1.1 Hits US & Europe: How to Download the Update

by

Samsung’s One UI 6.1.1 update is finally rolling out to the Galaxy S24 series and other recent devices in the US and Europe, packed with exciting AI-driven tools that make your device smarter and more creative. The update, though hefty at 2.8GB, brings features like Sketch to Image, turning simple doodles into polished artwork, and … Read more

How AI-Enhanced Stethoscopes Are Shaping the Future of Prenatal Care

by

The integration of AI into prenatal care, particularly through AI-powered stethoscopes, is transforming how we monitor pregnancy health. These devices can detect early signs of fetal and maternal heart issues by analyzing heart patterns that might otherwise go unnoticed. With machine learning algorithms, they provide real-time insights, making it easier for healthcare providers to diagnose … Read more

Africa’s Fight Against Mpox: More Than Just Vaccines

by

As Africa contends with the ongoing mpox outbreak, the situation underscores a need for more than just vaccines. While doses have started arriving, countries like the Democratic Republic of Congo face multiple health crises such as cholera, measles, and malaria. According to Michael Ryan, the WHO’s executive director for Health Emergencies, the question remains: “If … Read more